This inventor holds 2 USPTO granted patents. Top assignees: Altergon S. a. & Ricerfarma Srl., Altergon Sa. Active years: 1990.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1990
Title: Antonio Ziggiotti: Innovator in Pharmaceutical Compositions
Introduction
Antonio Ziggiotti is a notable inventor based in Vezia, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in developing innovative compositions for oral administration. With a total of 2 patents to his name, Ziggiotti's work focuses on improving the efficacy and usability of pharmaceutical products.
Latest Patents
Ziggiotti's latest patents include a mouth-soluble pharmaceutical composition containing acetyl-cysteine. This composition is designed to treat affections of the oral cavity and is produced in the form of tablets that include alkaline, bicarbonates, carbohydrates, and fruit flavoring. Another significant patent involves a salt of diclofenac with a pyrrolidine compound. This water-soluble salt is prepared by dissolving diclofenac in an organic solvent, adding a cyclic organic base, and crystallizing the product. It is intended for use in pharmaceutical compositions that can be easily dissolved in water for oral administration.
Career Highlights
Throughout his career, Antonio Ziggiotti has worked with various companies, including Altergon S.A. and Ricerfarma Srl. His experience in these organizations has allowed him to refine his skills and contribute to the development of innovative pharmaceutical solutions.
Collaborations
Ziggiotti has collaborated with notable professionals in the industry, including Michele Di Schiena and Paolo Lualdi. These partnerships have further enhanced his ability to create effective pharmaceutical compositions.
Conclusion
Antonio Ziggiotti is a distinguished inventor whose work in pharmaceutical compositions has made a significant impact in the field. His innovative approaches to drug formulation continue to pave the way for advancements in oral medication.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
